Saline Solution, Hypertonic: Clinical Trials

12 trials of Saline Solution, Hypertonic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 12
Phase 24Completed 4

Follow Saline Solution, Hypertonic: new trials by email Literature Review of Saline Solution, Hypertonic trials Research Report on Saline Solution, Hypertonic

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection
Continuous Bladder Irrigation with distilled water, Continuous Bladder Irrigation with normal saline, Continuous Bladder Irrigation with hypertonic saline - Bladder (Urothelial, Transitional Cell) Cancer, Nonmuscle Invasive Bladder Cancer
Phase 2 / Phase 3CompletedAin Shams University1502024-10-012025-12-29
Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
Hypertonic saline solution plus intravenous furosemide, Intravenous furosemide - Heart Failure
Phase 3CompletedPuerta de Hierro University Hospital1672021-01-012023-11-09
Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)
Hypertonic saline, Carbocysteine 750 MG - Bronchiectasis
Phase 3CompletedBelfast Health and Social Care Trust2882018-06-272025-05-02
Treating Brain Swelling in Pediatric Cerebral Malaria
Mechanical ventilation, Hypertonic saline - Malaria, Cerebral
Phase 3CompletedMichigan State University572018-01-082025-03-17
Comparison of the Effects of an Hypertonic Solution With Ringer Lactate on Right Ventricular Function Following Cardiac Surgery
Ringer Lactate (10ml/kg) fluid expansion, Hypertonic saline (3ml/kg) fluid expansion - Right Ventricular Impaired Function, Hypovolemia
Phase 3CompletedUniversity Hospital, Grenoble302016-08-012018-04-30
Saline Hypertonic in Preschoolers + CT
Active Treatment Group 7% Hypertonic Saline, Control Group 0.9% Isotonic Saline - Cystic Fibrosis
Phase 2 / Phase 3CompletedUniversity of Washington, the Collaborative Health Studies Coordinating Center1162015-03-242024-03-12
Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis
3% Saline, 0.9% Normal Saline - Acute Viral Bronchiolitis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris7782012-10-012014-07-28
Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
furosemide and hypertonic saline solution, furosemide - Congestive Heart Failure, Renal Insufficiency
Phase 3CompletedAspirus Heart and Vascular Institute-Research and Education502009-11-012012-02-09
The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis
hypertonic saline (7 %) and isotonic saline (0.9%) - Cystic Fibrosis
Phase 3CompletedThe Hospital for Sick Children202008-03-012013-09-02
Nebulized Hypertonic Saline for Bronchiolitis
Nebulized 3% saline, Nebulized 0.9% saline - Bronchiolitis
Phase 2 / Phase 3CompletedChildren's Hospital Los Angeles4472008-02-012024-11-05
The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.
3 % hypertonic saline - Bronchiolitis
Phase 2 / Phase 3CompletedSheikh Khalifa Medical City2003-11-012007-05-07
The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis
hypertonic saline - Cystic Fibrosis
Phase 3CompletedRoyal Prince Alfred Hospital, Sydney, Australia1642000-09-012006-10-09

Conditions studied

Bronchiolitis (3)  ·  Cystic Fibrosis (3)  ·  Heart Failure (2)  ·  Respiratory Tract Diseases (2)  ·  Bronchial Diseases (1)  ·  Bronchiectasis (1)  ·  Bronchiolitis, Viral (1)  ·  Cardio-Renal Syndrome (1)  ·  Coma (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypovolemia (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Malaria, Cerebral (1)

Sponsors

Ain Shams University (1)  ·  Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Belfast Health and Social Care Trust (1)  ·  Children's Hospital Los Angeles (1)  ·  Michigan State University (1)  ·  Puerta de Hierro University Hospital (1)  ·  Royal Prince Alfred Hospital, Sydney, Australia (1)  ·  Sheikh Khalifa Medical City (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Grenoble (1)  ·  University of Washington, the Collaborative Health Studies Coordinating Center (1)

Countries

Canada (3)  ·  France (3)  ·  United States (3)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Italy (1)  ·  Malawi (1)  ·  Netherlands (1)  ·  United Arab Emirates (1)  ·  United Kingdom (1)

Top investigators

Brian A Kuzik, MD, FRCP (1)  ·  Felix Ratjen, MD (1)  ·  Felix Ratjen, MD, PhD, FRCPC (1)  ·  German Larrain, MD (1)  ·  Harm Tiddens, MD, PhD (1)  ·  J. Stuart Elborn (1)  ·  Margaret Rosenfeld, MD, MPH (1)  ·  Marta Cobo Marcos, MD (1)  ·  Peter T P Bye, PhD (1)  ·  Richard S Engelmeier, MD (1)  ·  Stephanie Davis, MD (1)  ·  Stephen Stick, MD, PhD (1)  ·  Susan Wu, MD (1)  ·  Terrie E Taylor, DO (1)  ·  Vincent Gajdos, MD, PhD (1)

Results publications

PMID 37319354, PMID 16421364, PMID 20435858, PMID 24862623, PMID 28586918, PMID 34020114, PMID 35286860

NIH funding

U01AI126610 (1)